Should I buy Booz Allen Hamilton (BAH) stock or is it too late?
⭐ The most reliable of them, either direction: Truist Securities — 68% of its targets hit on this sector (212 calls tested). It aims for $85 (+18 %), call made on October 9, 2026, maturing on October 9, 2027 (5 d ago).
Firm-by-firm track record on Booz Allen Hamilton
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| JP Morgan | 88 % | +25.7 % | 8 | $85 +18% |
| Barclays | 91 % | +20.2 % | 11 | $120 +66% |
| Raymond James | 86 % | +14.9 % | 7 | $150 +107% |
| B of A Securities | 67 % | +11.2 % | 6 | $75 +4% |
| Stifel | 75 % | +10.2 % | 8 | $110 +52% |
| Jefferies | 67 % | +9.4 % | 6 | $75 +4% |
| Wells Fargo | 57 % | +0.7 % | 23 | $85 +18% |
| Goldman Sachs | 57 % | -2.4 % | 7 | $65 -10% |
✅ Reasons to believe
- The most reliable firm on BAH, JP Morgan (88% hit rate, 8 scored calls), targets $85 (call made on May 26, 2026, maturing on May 26, 2027) (+18%) in its most recent call, and $90 (call made on October 27, 2025, maturing on October 27, 2026) (+24%) in the one coming due soonest.
- Pays a dividend (3.8% yield), raised for 10 years — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 10 ratings, 4 are neutral and 3 are sells.
- Limited upside: the median target is only +7% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on BAH
Median target $78 (+7%) · 10 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Booz Allen Hamilton now?
We won't decide for you. The facts: 30% of analysts rate it a buy, median target $78 (+7%), and JP Morgan (most reliable on BAH, 88%) targets $85. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Booz Allen Hamilton?
Not according to analysts: the median target ($78) is still +7% above the current price ($72) (most reliable on BAH: JP Morgan, 88%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Booz Allen Hamilton still worth investing in?
It depends on the gap between the price ($72) and its estimated value: analysts target $78 on median (+7%), with 30% buys (most reliable on BAH: JP Morgan, 88%). Cross-check with their real reliability on BAH and the cautions above. Information, not advice.
What's the main risk in buying BAH?
The consensus is not unanimous: of 10 ratings, 4 are neutral and 3 are sells.
→ Go deeper: the full Booz Allen Hamilton profile (consensus, analyst reliability, price target, performance).